| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 101 | Prebiotic composition | JP2004558076 | 2003-12-11 | JP2006509797A | 2006-03-23 | ギブソン，グレン・アール; コリーダ，ソフイア |
| 本発明は、下痢や便秘のような炎症性腸疾患及び関連疾患をコントロールするためのオリゴ糖を含む栄養組成物に関する。 | ||||||
| 102 | Nutritional formulations containing prebiotic substances | JP2001559444 | 2001-02-15 | JP2003522784A | 2003-07-29 | ジェフリー・エル・ウィルソン |
| (57)【要約】 オリゴフルクトースおよびシアリルラクトースを含有する栄養組成物が提供される。 | ||||||
| 103 | Use of indigestible oligosaccharides for the treatment and prevention of human otitis media | JP50587997 | 1996-07-02 | JP2002502357A | 2002-01-22 | オストロム，カリン・マーガレツト; ドーナレツク，マーガレツト・アイワン・ハルピン; ヒルテイ，ミロ・デユーエイン |
| (57)【要約】 消化不能オリゴ糖を腸内投与することによる、幼児における中耳炎の発症率の低減方法を提供する。 より詳細には、本発明は、中耳炎発症率の低減方法であって、フルクトオリゴ糖、フルクトサン、キシロオリゴ糖、及びガラクトオリゴ糖からなる群から選択される消化不能オリゴ糖をヒトに投与することを特徴とする該方法に関する。 消化不能オリゴ糖は、酵素合成、化学技術によって製造でき、又は植物物質から単離でき、栄養製品、キャンディ、錠剤、チューインガム、ドロップ、牛乳製品、ヨーグルトなどの形態で投与する。 本発明の好適実施態様では、消化不能オリゴ糖はＤＰ２〜２０を有し、より好ましくはフルクトオリゴ糖ＧＦ 2 、ＧＦ 3 、及びＧＦ 4である。 | ||||||
| 104 | And non-reducing oligosaccharide a method for manufacturing the same, and applications | JP16748694 | 1994-06-28 | JP3182679B2 | 2001-07-03 | 隆彦 万代; 俊雄 三宅; 利行 杉本; 孝 渋谷 |
| 105 | Nonreducing oligosaccharide, its production and use thereof | JP5437794 | 1994-03-01 | JPH0770165A | 1995-03-14 | BANDAI TAKAHIKO; SHIBUYA TAKASHI; SUGIMOTO TOSHIYUKI; MIYAKE TOSHIO |
| PURPOSE:A novel nonreducing oligosaccharide having a trehalose structure in its molecule, its production and use thereof. CONSTITUTION:A nonreducing oligosaccharide represented by the general formula: alpha-D-oligoglycosyl-alpha-D-oligoglucoside. The production process for this nonreducing saccharide is to allow a trans-glycosidase to act on an aqueous solution containing trehalose and alpha-glycosyl saccharide or an aqueous solution containing a non-reducing saccharide bearing the trehalose structure on the chain terminal. The beverage, cosmetics and medicinal preparation containing this oligosaccharide. | ||||||
| 106 | Method for purifying substance for proliferating bifidobacterium | JP15559689 | 1989-06-20 | JPH0322971A | 1991-01-31 | MASAI TERUHISA; SHIBUTA TAKANOBU; YOSHIDA YASUYUKI; SUZUKI YASUSUKE |
| PURPOSE: To nearly completely separate impurities such as protein, salts, etc., existing together and purify the title substance so as to be able to use for various kind of applications by successively applying ultrafiltration membrane treatment, active carbon treatment and electric dialysis treatment to a soybean extract. CONSTITUTION: Extract of soybean (treated material) or soybean whey or treated material thereof is subjected to ultrafiltration membrane treatment with an ultrafiltration membrane, preferably having 40000-60000 fractional molecular weight. Then the treated material is subjected to active carbon treatment and then subjected to electrodialysis to carry out purification of the title substance. Furthermore, after electrodialysis treatment, ion exchange resin treatment is preferably carried out. COPYRIGHT: (C)1991,JPO&Japio | ||||||
| 107 | METHOD OF GENERATING A SACCHARIDE CONTAINING A GALACTOSE AND A FRUCTOSE MOIETY EMPLOYING ENZYME WITH TRANSGALACTOSYLATING ACTIVITY | EP15812960.1 | 2015-11-06 | EP3215628A1 | 2017-09-13 | LARSEN, Morten Krog; CRAMER, Jacob Flyvholm; EISELE, Thomas |
| A method of generating a saccharide, especially lactulose or lactosucrose, in the presence of a transgalactosylase enzyme, is described herein. | ||||||
| 108 | SPRAY-DRIED COMPOSITION COMPRISING BETA-GALACTOSIDASE HAVING TRANSGALACTOSYLATING ACTIVITY IN COMBINATION WITH MALTODEXTRIN AND/OR NACL AND APPLICATION OF THE COMPOSITION | EP15791590.1 | 2015-11-06 | EP3215613A1 | 2017-09-13 | LARSEN, Morten Krog; CRAMER, Jacob Flyvholm; LARSEN, Bjarne; DANGAARD, Jens |
| A spray-dried composition comprising an enzyme which is a β-galactosidase having transgalactosyiating activity and a maltodextrin and/or sodium chloride. | ||||||
| 109 | Method for stimulating intestinal barrier integrity after non-natural birth | EP11178047.4 | 2006-10-06 | EP2407036B1 | 2015-11-04 | Schmitt, Joachim; Boehm, Günther; Beermann, Christopher |
| The present invention relates to methods for feeding and to compositions to be adminis | ||||||
| 110 | INFANT FORMULA WITH HIGH SN-2 PALMITATE AND OLIGOFRUCTOSE | EP12799298.0 | 2012-10-29 | EP2800480A2 | 2014-11-12 | YAO, Manjiang; RAMANUJAM, Kalathur S.; KULLEN, Martin Jon; FITZGERALD, Margaret |
| An infant formula having a relatively high content of triglycerides having palmitic acid in the sn-2 position. The formula may include oligofructose. The formula may also include at least one omega 6 fatty acid and at least one omega 3 fatty acid. The formula may also have a relatively low protein content and an alpha-lactalbumin content similar to human milk. The invention also includes a method for improving the stool consistency, increasing bifidobacteria in the colon, and reducing calcium soaps in the stool of a formula-fed infant. | ||||||
| 111 | Method for stimulating intestinal barrier integrity after birth by caesarean section | EP09161674.8 | 2006-10-06 | EP2105055B1 | 2014-01-22 | Schmitt, Joachim; Boehm, Günther; Beermann, Christopher |
| The present invention relates to methods for feeding and to compositions to be adminis | ||||||
| 112 | IMPROVED TOLERANCE IN A LOW CALORIE INFANT FORMULA | EP11809042.2 | 2011-12-21 | EP2658397A1 | 2013-11-06 | CLINGER, Christine L.; MARRIAGE, Barbara J. |
| The present disclosure is directed to low calorie infant formulas, and in particular, low calorie infant formulas that have a low buffering capacity, exhibit an increased rate of protein hydrolysis and digestion, and have an improved tolerance, as compared to full calorie infant formulas. Also disclosed are low calorie liquid infant formulas that have a reduced (i.e., "low") micronutrient content on a per volume basis, and exhibit an overall improvement in the physical properties of the formula, as compared to low calorie liquid infant formulas having a higher micronutrient content. | ||||||
| 113 | Method for stimulating the intestinal flora | EP13171226.7 | 2006-10-20 | EP2638812A1 | 2013-09-18 | Boehm, Günther; Knol, Jan; Stahl, Bernd |
The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c)at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants. |
||||||
| 114 | FOOD COMPOSITIONS COMPROMISING DRIED PROBIOTICS, METHODS OF MANUFACTURE AND USES THEREOF | EP10711953.9 | 2010-03-26 | EP2410867A1 | 2012-02-01 | RUDOLPH, Marvin, J. |
| The present invention is directed to a food composition including an edible base mix component and a dried probiotic component which that may be stored at room temperature and converted to a frozen dessert with minimal effects to the viability of probiotics. Accordingly, a consumer ingesting the frozen dessert is provided with a beneficial amount of viable probiotics. Also provided herein are one or more methods for manufacturing the food compositions and using the subject food composition in frozen dessert products. | ||||||
| 115 | NUTRITIONAL FORMULATIONS CONTAINING LACTO-N-NEOTETRAOSE | EP98913279.0 | 1998-03-30 | EP0973413B2 | 2011-11-09 | PRIETO, Pedro, A.; KROENING, Terry, A. |
| A nutritional formulation containing an effective amount of Lacto-N-neoTetraose to simulate the growth and/or metabolic activity of Bifidobacterium is provided. A process of inhibiting bacterial infections caused by Bacteroides, Clostridium, and E. coli including the step of feeding the nutritional composition to a subject is also provided. | ||||||
| 116 | Method for stimulating the intestinal flora in infants delivered by caesarean section | EP09011197.2 | 2006-10-20 | EP2140771A1 | 2010-01-06 | Boehm, Günther; Stahl, Bernd; Knol, Jan |
The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c)at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants. |
||||||
| 117 | METHOD FOR STIMULATING THE INTESTINAL FLORA | EP06806443.5 | 2006-10-20 | EP1940250B1 | 2009-09-16 | BOEHM, Günther; STAHL, Bernd; KNOL, Jan |
| The present invention relates to methods for feeding and to compositions to be adminis | ||||||
| 118 | PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION | EP06799537.3 | 2006-10-06 | EP1940246A1 | 2008-07-09 | SCHMITT, Joachim; STAHL, Bernd; KNOL, Jan |
| The present invention relates to methods for feeding and to compositions to be adminis | ||||||
| 119 | Method for the preparation of a substance capable of proliferating bifidobacteria growth | EP90306429.3 | 1990-06-13 | EP0404425B1 | 1995-03-29 | Masai, Teruhisa; Shibuta, Takanobu; Yoshida, Yasuyuki; Suzuki, Yohsuke |
| 120 | Food-stuff and a process for its preparation | EP88850339.8 | 1988-10-12 | EP0313533A1 | 1989-04-26 | Lundblad, Arne |
Food-stuff, particularly based on ruminants milk, having added thereto Lacto-N-tetraose in a gastro-intestinally effective amount; and |
||||||
QQ群二维码
意见反馈
意见反馈